Researchers developed a deep learning (DL) model to estimate 30.0-day mortality risk for pneumonia.
BridgeBio spins out oncology company as it focuses on heart drug
BridgeBio Pharma is spinning out its oncology subsidiary into a fully independent company, as it concentrates its resources on an anticipated launch of its pivotal